US 9803202
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted A61PA61P9/00A61P9/04
Quick answer
US patent 9803202 (Oligonucleotide-based inhibitors comprising locked nucleic acid motif) held by MIRAGEN THERAPEUTICS, INC. expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P9/00, A61P9/04, A61P9/10